MBIO Mustang Bio, Inc.

$0.59

Mustang Bio, Inc. (MBIO) is expected to report earnings on November 4, 2026, after the market close.

Mustang Bio Reported Earnings
Wednesday, August 5, 2026 · 12:00 AM ET
Earnings Date
Nov 4
Wednesday · 6:50 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Mustang Bio, Inc.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases.

Sector

Healthcare